ECCMID 2019

 

AWG Member Company Participation at ECCMID 2019

Twelve AWG member companies present data from their clinical and research programs at the 29th annual meeting of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019) in Amsterdam, Netherlands, April 13 – 16, 2019. In addition to poster & oral presentations, representatives from AWG member companies will participate in various panels and symposiums addressing the state of the antimicrobial development pipeline.

ECCMID is an annual scientific meeting that brings together the leading experts in the fields of clinical microbiology, infectious disease and infection control from across the globe to present and discuss the latest developments in the laboratory and in the clinic to advance research in a wide array of infectious diseases.

 

Saturday, April 13th

Oral Abstract Session: Issues in antifungal treatment
Time: 10:00 a.m. – 12:00 p.m. CET
Location: Hall H

Cidara Therapeutics:
11:36 a.m. – 11:46 a.m. CET

Oral Abstract Session: Novel antimicrobial agents and discovery strategies
Time: 1:30 p.m. – 3:30 p.m. CET
Location: Hall M

Summit Therapeutics:
1:42 p.m. – 2:42 p.m. CET

Entasis Therapeutics:
3:06 p.m. – 3:17 p.m. CET

 

Mini-oral ePoster Session: Antibacterial activity of unusual combinations
Time: 1:30 p.m. – 2:30 p.m. CET
Location: Arena 2

ContraFect Corporation:
1:48 p.m. – 1:53 p.m. CEST

 

Integrated Symposium: Update on acute bacterial skin and skin structure infection: current challenges and new therapeutic agents
Time: 1:30 p.m. – 3:30 p.m. CET
Location: Hall D

Melinta Therapeutics:

Mini-oral ePoster Session: Clinical trials with recently approved or late-stage development antibiotics
Time: 2:45 p.m. – 3:45 p.m. CET
Location: Arena 5

Entasis Therapeutics:
2:45 p.m. – 2:50 p.m. CET

Motif Bio:
2:57 p.m. – 3:02 p.m. CET

 

Paratek Pharmaceuticals:
3:09 – 3:14 a.m. CET

 

3:21 – 3:26 p.m. CET

 

Oral Abstract Session: Novel approaches to fungal diseases
Time: 2:45 p.m. – 3:45 p.m. CET
Location: Hall M

Amplyx:

 

Cidara Therapeutics:
3:21 p.m. – 3:31 p.m. CET

 

Paper Poster Session: Clinical pharmacokinetics, treatment strategies and prescribing of antifungals
Time: 3:30 p.m. – 4:30 p.m. CET
Location: Paper Poster Area

 

Cidara Therapeutics:

 

 

SCYNEXIS:

 

Paper Poster Session: Biofilm eradication strategies
Time: 3:30 p.m. – 4:30 p.m. CET
Location: Paper Poster Area

 

ContraFect Corporation:

 

Paper Poster Session: Clinical Aspects of Community-Acquired Pneumonia and Respiratory Tract Infection
Time: 3:30 p.m. – 4:30 p.m. CET
Location: Paper Poster Area

 

Paratek Pharmaceuticals:

 

Nabriva Therapeutics:

 

 

Paper Poster Session: Other issues and diverse latebreaker aspects
Time: 3:30 p.m. – 4:30 p.m. CET
Location: Paper Poster Area

 

SCYNEXIS:

 

 

Melinta Therapeutics:

 

Sunday, April 14th

Oral Session: Unconventional approaches to skin infections
Time: 10:00 a.m. – 12:00 p.m. CET
Location: Hall L

 

Melinta Therapeutics:

 

Pipeline Corner: Therapeutics pipeline corner
Time: 12:15 p.m. – 1:15 p.m. CET
Location: Arena 3

 

ContraFect Corporation:

 

Entasis Therapeutics

 

Summit Therapeutics

 

Paper Poster Session: New beta-lactamase inhibitors: in vitro studies
Time: 1:30 p.m. – 2:30 p.m. CET
Location: Paper Poster Area

 

Entasis Therapeutics:

 

 

 

VenatoRx Pharmaceuticals:

 

 

 

 

 

 

 

 

 

Monday, April 15th 

Mini-oral ePoster Session: Antifungals: novel drugs, novel dosing?
Time: 11:00 a.m. – 12:00 p.m. CET
Location: Arena 2

 

Cidara Therapeutics:
11:48 a.m. – 11:53 a.m. CET

 

Amplyx:

11:06 a.m. – 11:11 a.m. CET

 

SCYNEXIS:

11:00 a.m. – 11:05 a.m. CET

 

11:42 a.m. – 11:47 a.m. CET

 

 

Paper Poster Session: Sexually transmitted infections complicated by antimicrobial resistance
Time: 12:30 p.m. – 1:30 p.m. CET
Location: Paper Poster Area

 

Iterum Therapeutics:

 

Paper Poster Session: Diverse methodologies for MIC testing in Gram-negatives
Time: 12:30 p.m. – 1:30 p.m. CET
Location: Paper Poster Area

 

Melinta Therapeutics:

 

 

Nabriva Therapeutics:

 

 

Paper Poster Session:  Urinary tract infections

Time: 12:30 p.m. – 1:30 p.m. CET
Location: Paper Poster Area

 

Iterum Therapeutics:

Oral Abstract Session: New therapeutic strategies in viral infections

Time: 1:30 p.m. – 3:30 p.m. CET
Location: Hall M

 

Cidara Therapeutics:

2:18 p.m. – 2:28 p.m. CET

 

 

Paper Poster Session:  In vitro activity of investigational antibacterial agents

Time: 1:30 p.m. – 2:30 p.m. CET
Location: Paper Poster Area

 

Cidara Therapeutics:

 

Nabriva Therapeutics:

 

 

Paper Poster Session: In vitro activity of newer antibacterial agents

Time: 1:30 p.m. – 2:30 p.m. CET
Location: Paper Poster Area

 

Paratek Pharmaceuticals:

 

Melinta Therapeutics:

 

 

Motif Bio:

 

 

Paper Poster Session: Clinical efficacy studies for antimicrobial agents

Time: 1:30 p.m. – 2:30 p.m. CET
Location: Paper Poster Area

 

Paratek Pharmaceuticals:

 

 

Paper Poster Session: Recent research on the pharmacokinetics and safety of antibacterial agents

Time: 1:30 p.m. – 2:30 p.m. CET
Location: Paper Poster Area

 

Paratek Pharmaceuticals:

 

 

Entasis Therapeutics:

 

Nabriva Therapeutics:

 

 

VenatoRx Pharmaceuticals:

 

 

Paper Poster Session: Safety of Antibacterial Agents in the Clinic

Time: 1:30 p.m. – 2:30 p.m. CET
Location: Paper Poster Area

 

Paratek Pharmaceuticals:

 

 

Paper Poster Session: Evaluation of diverse antimicrobials in vitro and experimental models

Time: 1:30 p.m. – 2:30 p.m. CET
Location: Paper Poster Area

 

Iterum Therapeutics:

 

Entasis Therapeutics:

 

 

Integrated Symposium: Light and shadows in the management of serious multidrug-resistant Gram-negative infections

Time: 4:00 p.m. – 6:00 p.m. CET
Location: Hall F

 

Melinta Therapeutics:

 

 

Tuesday, April 16th 

 

Oral Session: Recent clinical trials

Time: 11:00 a.m. – 12:00 p.m. CET
Location: Hall N

 

ContraFect Corporation:

11:24 a.m. – 11:34 a.m. CEST

 

SCYNEXIS:

 

 

Mini-oral ePoster Session: Defining exposure, efficacy and safety of new antimicrobial agents

Time: 11:00 a.m. – 12:00 p.m. CET
Location: Arena 2

 

Amplyx:

 

Nabriva Therapeutics:

 

VenatoRx Pharmaceuticals:

 

 

 

Paper Poster Session: Virulence and outcomes of fungal infections

Time: 12:30 p.m. – 1:30 p.m. CET
Location: Paper Poster Area

 

Cidara Therapeutics:

 

 

Paper Poster Session: Antifungal susceptibility and resistance in yeast and molds from around the world

Time: 12:30 p.m. – 1:30 p.m. CET
Location: Paper Poster Area

 

Cidara Therapeutics:

 

 

 

Paper Poster Session: Skin and Soft Tissue Infections

Time: 12:30 p.m. – 1:30 p.m. CET
Location: Paper Poster Area

 

Paratek Pharmaceuticals:

 

Motif Bio:

 

 

Paper Poster Session: Disk diffusion susceptibility testing

Time: 12:30 p.m. – 1:30 p.m. CET
Location: Paper Poster Area

 

Melinta Therapeutics:

 

 

Oral Abstract Session: PK/PD to guide dosing in special populations

Time: 1:30 p.m. – 3:30 p.m. CET
Location: Hall L

 

Motif Bio:

  • #O1162 Pharmacokinetics of iclaprim by age, weight, race and renal/hepatic function in patients with acute bacterial skin and skin structure infections: phase III REVIVE trials

https://www.eccmidlive.org/#!resources/pharmacokinetics-of-iclaprim-by-age-weight-race-and-renal-hepatic-function-in-patients-with-acute-bacterial-skin-and-skin-structure-infections-phase-iii-revive-trials-dae8b942-d512-4d56-98e6-b4888e5b7b42